Trial Profile
Phase II Trial of Irinotecan Plus Lenalidomide in Adult Patients With Recurrent Glioblastoma Multiforme
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 03 Mar 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Irinotecan
- Indications Glioblastoma
- Focus Therapeutic Use
- 03 Mar 2015 New trial record